Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger.
暂无分享,去创建一个
R. Moreno-Sánchez | S. Rodríguez-Enríquez | J. Neuzil | S. Ralph | Rafael Moreno-Sánchez | Stephen J Ralph | Jiri Neuzil | Sara Rodríguez-Enríquez
[1] A. Walch,et al. Inflammation and mitochondrial fatty acid β-oxidation link obesity to early tumor promotion , 2009, Proceedings of the National Academy of Sciences.
[2] B. D'Attoma,et al. Fatty Acid Synthase Hyperactivation in Human Colorectal Cancer: Relationship with Tumor Side and Sex , 2007, Oncology.
[3] Rodrigue Rossignol,et al. Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells , 2004, Cancer Research.
[4] E M Chance,et al. Metabolism of alternative substrates and the bioenergetic status of EMT6 tumor cell spheroids , 2000, NMR in biomedicine.
[5] H P Koeffler,et al. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Glazer,et al. Glutamate dehydrogenase activity related to histopathological grade of hepatocellular carcinoma in man. , 1974, Cancer research.
[7] H. Koeffler. Peroxisome proliferator-activated receptor γ and cancers , 2003 .
[8] R. Deberardinis,et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation , 2005, Oncogene.
[9] E. Barrett,et al. Characterization of glutamine transport by liver plasma membrane vesicles. , 1986, The American journal of physiology.
[10] H. R. Harding,et al. DEPRESSION OF ALANINE TRANSAMINASE ACTIVITY IN THE LIVER OF RATS BEARING WALKER CARCINOMA 256. , 1964, Cancer research.
[11] O. Warburg. On the origin of cancer cells. , 1956, Science.
[12] F. Kuhajda,et al. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. , 2001, Biochemical and biophysical research communications.
[13] F. Kuhajda,et al. Fatty acid synthase and cancer: new application of an old pathway. , 2006, Cancer research.
[14] Catherine Jones,et al. Increased expression of uncoupling protein 2 in HepG2 cells attenuates oxidative damage and apoptosis , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[15] I. T. de Almeida,et al. Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation defects. , 2005, Molecular genetics and metabolism.
[16] L. Augenlicht,et al. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. , 1994, Cancer research.
[17] K. Kristiansen,et al. Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways. , 2001, Carcinogenesis.
[18] Mark Woodward,et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence , 2009, International journal of cancer.
[19] D. Cao,et al. Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. , 2009, Biochemical and biophysical research communications.
[20] Nicola Zamboni,et al. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.
[21] J. Phang. The regulatory functions of proline and pyrroline-5-carboxylic acid. , 1985, Current topics in cellular regulation.
[22] Henri Brunengraber,et al. Mass isotopomer study of anaplerosis from propionate in the perfused rat heart. , 2007, Archives of biochemistry and biophysics.
[24] J. Wands,et al. The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. , 2008, Cancer research.
[25] S. Kölker,et al. Methylmalonic acid — an endogenous toxin? , 2005, Cellular and Molecular Life Sciences.
[26] K. Tipton,et al. The effects of magnesium ions on the interactions of ox brain and liver glutamate dehydrogenase with ATP and GTP. , 1984, The Biochemical journal.
[27] Sébastien Bonnet,et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. , 2007, Cancer cell.
[28] S. Weinhouse,et al. Metabolism of neoplastic tissue. IX. An isotope tracer study of glucose catabolism pathways in normal and neoplastic tissues. , 1956, The Journal of biological chemistry.
[29] A. Rivera,et al. Proline Oxidase Induces Apoptosis in Tumor Cells, and Its Expression Is Frequently Absent or Reduced in Renal Carcinomas* , 2003, The Journal of Biological Chemistry.
[30] K. Unsicker,et al. Neurodegeneration in Methylmalonic Aciduria Involves Inhibition of Complex II and the Tricarboxylic Acid Cycle, and Synergistically Acting Excitotoxicity* , 2002, The Journal of Biological Chemistry.
[31] J. Grem,et al. Metabolism and action of amino acid analog anti-cancer agents. , 1990, Pharmacology & therapeutics.
[32] T. Bisogno,et al. Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. , 2006, Biochimica et biophysica acta.
[33] R. Moreno-Sánchez,et al. Determining and understanding the control of glycolysis in fast‐growth tumor cells , 2006, The FEBS journal.
[34] R. Rodenburg,et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. , 2006, The Biochemical journal.
[35] R. Feinman,et al. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2 , 2009, Cancer Cell International.
[36] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[37] M. Washington,et al. Tumorigenesis and Neoplastic Progression High Fat Diet Induced Hepatic Steatosis Establishes a Permissive Microenvironment for Colorectal Metastases and Promotes Primary Dysplasia in a Murine Model , 2010 .
[38] A. Witkowski,et al. Down-regulation of Mitochondrial Acyl Carrier Protein in Mammalian Cells Compromises Protein Lipoylation and Respiratory Complex I and Results in Cell Death* , 2009, Journal of Biological Chemistry.
[39] Timo Heikkilae,et al. Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase. , 2007, Journal of medicinal chemistry.
[40] J. Stuart,et al. Superoxide activates mitochondrial uncoupling proteins , 2002, Nature.
[41] Mijin Yun,et al. The Importance of Acetyl Coenzyme A Synthetase for 11C-Acetate Uptake and Cell Survival in Hepatocellular Carcinoma , 2009, Journal of Nuclear Medicine.
[42] B. Brors,et al. Mitochondrial fatty acid synthesis: a relic of endosymbiontic origin and a specialized means for respiration , 1997, FEBS letters.
[43] W. Souba,et al. Modulation of Cellular Proliferation Alters Glutamine Transport and Metabolism in Human Hepatoma Cells , 1994, Annals of surgery.
[44] Hege Wergedahl,et al. Effect of dietary tetradecylthioacetic acid on colon cancer growth studied by dynamic contrast enhanced MRI , 2007, Cancer biology & therapy.
[45] P. Scardino,et al. Expression of neutral amino acid transporter ASCT2 in human prostate. , 2003, Anticancer research.
[46] Y. Fujibayashi,et al. Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET. , 2009, Nuclear medicine and biology.
[47] R. D. de Souza,et al. Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.
[48] Y. Liu,et al. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers , 2008, Oncogene.
[49] J. Phang,et al. The metabolism of proline, a stress substrate, modulates carcinogenic pathways , 2008, Amino Acids.
[50] J. Peters,et al. Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor α (PPARα)* , 1998, The Journal of Biological Chemistry.
[51] W. Souba,et al. Regulation of glutamine synthetase in human breast carcinoma cells and experimental tumors. , 1997, Surgery.
[52] T. Seng,et al. C75 [4-Methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic Acid] Activates Carnitine Palmitoyltransferase-1 in Isolated Mitochondria and Intact Cells without Displacement of Bound Malonyl CoA , 2005, Journal of Pharmacology and Experimental Therapeutics.
[53] D. Thomas,et al. Divergent evolution of pyrimidine biosynthesis between anaerobic and aerobic yeasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Neuzil,et al. Mitochondria as targets for cancer therapy. , 2009, Molecular nutrition & food research.
[55] G. Chang,et al. Purification and characterization of the cytosolic NADP(+)-dependent malic enzyme from human breast cancer cell line. , 1991, European journal of biochemistry.
[56] Y. Liu,et al. Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling , 2006, Oncogene.
[57] B. Fuchs,et al. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? , 2005, Seminars in cancer biology.
[58] J. Phang,et al. Genetic evidence for a common enzyme catalyzing the second step in the degradation of proline and hydroxyproline. , 1979, The Journal of clinical investigation.
[59] M. Wajner,et al. Inhibition of succinate dehydrogenase and β-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats , 1993, Journal of Inherited Metabolic Disease.
[60] Barbara M. Bakker,et al. Hierarchical and metabolic regulation of glucose influx in starved Saccharomyces cerevisiae. , 2005, FEMS yeast research.
[61] J. Matés,et al. Inhibition of glutaminase expression increases Sp1 phosphorylation and Sp1/Sp3 transcriptional activity in Ehrlich tumor cells. , 2005, Cancer letters.
[62] V. Vasiliou,et al. Removal of acetaldehyde from the body. , 2007, Novartis Foundation symposium.
[63] M. Gomez-Lazaro,et al. Reactive Oxygen Species and p38 Mitogen-Activated Protein Kinase Activate Bax to Induce Mitochondrial Cytochrome c Release and Apoptosis in Response to Malonate , 2007, Molecular Pharmacology.
[64] Y. Pu,et al. Diet, vegetarian food and prostate carcinoma among men in Taiwan , 2005, British Journal of Cancer.
[65] L. Baggetto,et al. Deviant energetic metabolism of glycolytic cancer cells. , 1992, Biochimie.
[66] H. Waterham,et al. A homozygous nonsense mutation in the methylmalonyl‐CoA epimerase gene (MCEE) results in mild methylmalonic aciduria , 2006, Human Mutation.
[67] H. Ahorn,et al. Characterization of cytosolic malic enzyme in human tumor cells , 1994, FEBS letters.
[68] M. Brin,et al. The inhibition of respiration by glucose, fructose, and mannose in the Ehrlich mouse ascites tumor. , 1956, Cancer research.
[69] F. Domann,et al. α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II , 2008, Oncogene.
[70] H. G. Coore,et al. Properties of pyruvate dehydrogenase of rat mammary tissue and its changes during pregnancy, lactation and weaning. , 1974, The Biochemical journal.
[71] M. Patel,et al. Ketone-body metabolism in glioma and neuroblastoma cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[72] R. Moreno-Sánchez,et al. Kinetics of transport and phosphorylation of glucose in cancer cells , 2009, Journal of cellular physiology.
[73] Bing-hui Li,et al. Inhibitory effects of flavonoids on animal fatty acid synthase. , 2004, Journal of biochemistry.
[74] D. Haro,et al. Ketogenic HMGCS2 Is a c-Myc Target Gene Expressed in Differentiated Cells of Human Colonic Epithelium and Down-Regulated in Colon Cancer , 2006, Molecular Cancer Research.
[75] T. Galeotti,et al. Pyruvate transport in tumour-cell mitochondria. , 1977, Biochimica et biophysica acta.
[76] A. Lehninger,et al. Purification, kinetic behavior, and regulation of NAD(P)+ malic enzyme of tumor mitochondria. , 1984, The Journal of biological chemistry.
[77] L. Klotz,et al. Dietary fat and prostate cancer. , 2004, The Journal of urology.
[78] A. Gescher,et al. Dietary polyphenolic phytochemicals—promising cancer chemopreventive agents in humans? A review of their clinical properties , 2007, International journal of cancer.
[79] Mulchand S Patel,et al. R-Lipoic Acid Inhibits Mammalian Pyruvate Dehydrogenase Kinase , 2004, Free radical research.
[80] H. Pitot. The comparative enzymology and cell origin of rat hepatomas. II. Glutamate dehydrogenase, choline oxidase, and glucose-6-phosphatase. , 1960, Cancer research.
[81] P. Pedersen,et al. Tumor mitochondria and the bioenergetics of cancer cells. , 1978, Progress in experimental tumor research.
[82] R. Cody,et al. Multicenter Phase II Study of Brequinar Sodium in Patients with Advanced Breast Cancer , 1993, American journal of clinical oncology.
[83] J. Phang,et al. Regulation and function of proline oxidase under nutrient stress , 2009, Journal of cellular biochemistry.
[84] P. J. Randle. The Interrelationships of Hormones, Fatty Acid and Glucose in the Provision of Energy , 1964, Postgraduate medical journal.
[85] M. Wajner,et al. Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production , 1997, Journal of Inherited Metabolic Disease.
[86] Mulchand S Patel,et al. Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases , 2001, Experimental & Molecular Medicine.
[87] A. Pardee,et al. Malonate inhibition of oxidations in the Krebs tricarboxylic acid cycle. , 1949, The Journal of biological chemistry.
[88] C. la Vecchia,et al. Alcohol and cancers of the upper aerodigestive tract in men and women. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[89] A. Schoolwerth,et al. Transport of metabolic substrates in renal mitochondria. , 1985, Annual review of physiology.
[90] M. Prentki,et al. A Role for ATP-Citrate Lyase, Malic Enzyme, and Pyruvate/Citrate Cycling in Glucose-induced Insulin Secretion* , 2007, Journal of Biological Chemistry.
[91] T. Seyfried,et al. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies , 2003, Journal of neurochemistry.
[92] Guoliang Xu,et al. Identification and Characterization of Propionylation at Histone H3 Lysine 23 in Mammalian Cells* , 2009, The Journal of Biological Chemistry.
[93] H. Morris,et al. Glutaminase activities and growth rates of rat hepatomas. , 1969, Cancer research.
[94] K.,et al. A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[95] H. Hamer. Short chain fatty acids and colonic health , 2009 .
[96] D. Hardie,et al. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. , 2001, Biochemical Society transactions.
[97] T. Seyfried,et al. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model , 2002, British Journal of Cancer.
[98] W. Zhou,et al. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells , 2009, Oncogene.
[99] E. Kandel,et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.
[100] H. Simmonds,et al. Severe Impairment of Nucleotide Synthesis Through Inhibition of Mitochondrial Respiration , 2004, Nucleosides, nucleotides & nucleic acids.
[101] R. Brady,et al. The synthesis of radioactive cholesterol and fatty acids in vitro. II. A further study of precursors. , 1951, Journal of Biological Chemistry.
[102] A. Meijer,et al. Control of rat-liver glutaminase by ammonia and pH. , 1983, European journal of biochemistry.
[103] Janardan K Reddy,et al. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[104] M. Medina,et al. Glutamine transport by vesicles isolated from tumour-cell mitochondrial inner membrane. , 1995, The Biochemical journal.
[105] E. L. Coe,et al. Glycolysis of small amounts of glucose by Ehrlich ascites carcinoma cells. , 1966, Cancer research.
[106] L. Reitzer,et al. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.
[107] C. Townsend,et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. , 2000, Cancer research.
[108] A. J. Lambert,et al. A signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling , 2003, The EMBO journal.
[109] F. Villarroya,et al. PPARs in the Control of Uncoupling Proteins Gene Expression , 2006, PPAR research.
[110] H. Ni,et al. Etomoxir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[111] Andrzej Witkowski,et al. Coupling of the de Novo Fatty Acid Biosynthesis and Lipoylation Pathways in Mammalian Mitochondria* , 2007, Journal of Biological Chemistry.
[112] Liang Tong,et al. Molecular mechanism for the regulation of human mitochondrial NAD(P)+-dependent malic enzyme by ATP and fumarate. , 2002, Structure.
[113] Y. Obara,et al. Regulation of uncoupling protein 2 expression by long-chain fatty acids and hormones in bovine mammary epithelial cells. , 2008, Biochemical and biophysical research communications.
[114] A. Cederbaum,et al. Fatty acid oxidation, substrate shuttles, and activity of the citric acid cycle in hepatocellular carcinomas of varying differentiation. , 1976, Cancer research.
[115] O. Niemelä,et al. Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. , 1999, Frontiers in bioscience : a journal and virtual library.
[116] G. Schuster,et al. Catalytic enzyme histochemistry and biochemical analysis of dihydroorotate dehydrogenase/oxidase and succinate dehydrogenase in mammalian tissues, cells and mitochondria , 1996, Histochemistry and Cell Biology.
[117] Timm Maier,et al. The Crystal Structure of a Mammalian Fatty Acid Synthase , 2008, Science.
[118] S. Joseph,et al. Localization and some properties of phosphate-dependent glutaminase in disrupted liver mitochondria. , 1980, The Biochemical journal.
[119] T. Roche,et al. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer , 2007, Cellular and Molecular Life Sciences.
[120] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[121] G. Yancey Gillespie,et al. Glucose Metabolism Heterogeneity in Human and Mouse Malignant Glioma Cell Lines , 2005, Journal of Neuro-Oncology.
[122] R. Surtees,et al. Physiology and pathophysiology of organic acids in cerebrospinal fluid , 1993, Journal of Inherited Metabolic Disease.
[123] A. Lehninger,et al. Isolated tumoral pyruvate dehydrogenase can synthesize acetoin which inhibits pyruvate oxidation as well as other aldehydes. , 1987, Biochemical and biophysical research communications.
[124] T. Roche,et al. Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates. , 2001, Archives of biochemistry and biophysics.
[125] J. Matés,et al. Antisense glutaminase inhibition modifies the O‐GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells , 2008, Journal of cellular biochemistry.
[126] J. Matés,et al. Co-expression of glutaminase K and L isoenzymes in human tumour cells. , 2005, The Biochemical journal.
[127] M. Andreeff,et al. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. , 2009, Cancer research.
[128] P. Bottoni,et al. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. , 2007, American journal of physiology. Cell physiology.
[129] O. Mamer,et al. Metabolism of methylmalonic acid in rats. Is methylmalonyl-coenzyme a racemase deficiency symptomatic in man? , 1983, The Journal of clinical investigation.
[130] S. Eaton,et al. Mitochondrial beta-oxidation. , 2004, European journal of biochemistry.
[131] C. Chaumontet,et al. Butyrate metabolism in human colon carcinoma cells: Implications concerning its growth‐inhibitory effect , 2009, Journal of cellular physiology.
[132] H. Blottière,et al. Butyrate metabolism upstream and downstream acetyl-CoA synthesis and growth control of human colon carcinoma cells. , 2000, European journal of biochemistry.
[133] J. Reddy,et al. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. , 2003, Current molecular medicine.
[134] R. B. Ramsey,et al. 3‐Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system 1 , 1978, Journal of neurochemistry.
[135] V. Zammit,et al. Distinct Kinetics of Carnitine Palmitoyltransferase I in Contact Sites and Outer Membranes of Rat Liver Mitochondria* , 2001, The Journal of Biological Chemistry.
[136] R. Cook,et al. Regulation of volatile fatty acid uptake by mitochondrial acyl CoA synthetases of bovine liver. , 1981, Journal of dairy science.
[137] J. Neuzil,et al. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents. , 2006, Recent patents on anti-cancer drug discovery.
[138] K. Paull,et al. Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar. , 1996, Biochemical and biophysical research communications.
[139] A. Sherry,et al. Propionate metabolism in the rat heart by 13C n.m.r. spectroscopy. , 1988, The Biochemical journal.
[140] I. Buchan,et al. Incident cancer burden attributable to excess body mass index in 30 European countries , 2010, International journal of cancer.
[141] E. Melhem,et al. Multi-slice proton MR spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. , 2001, AJNR. American journal of neuroradiology.
[142] M. Moore,et al. Short report: Multicenter phase II trial of brequinar sodium in patients with advanced melanoma , 1992 .
[143] G. Lenaz. The Mitochondrial Production of Reactive Oxygen Species: Mechanisms and Implications in Human Pathology , 2001, IUBMB life.
[144] Emma Saavedra,et al. Metabolic Control Analysis: A Tool for Designing Strategies to Manipulate Metabolic Pathways , 2008, Journal of biomedicine & biotechnology.
[145] S. Seneca,et al. Mutations in the X‐linked pyruvate dehydrogenase (E1) α subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency , 2000, Human mutation.
[146] P. Bottoni,et al. Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? , 2008, PPAR research.
[147] J. Mcgivan,et al. Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. , 2003, The Biochemical journal.
[148] G. Neil,et al. Acivicin. An antitumor antibiotic. , 1981, Cancer clinical trials.
[149] J. Mackey,et al. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer , 2008, British Journal of Cancer.
[150] R. Moreno-Sánchez,et al. Energy metabolism transition in multi‐cellular human tumor spheroids , 2008, Journal of cellular physiology.
[151] B. Hamprecht,et al. Purification of Cytosolic Malic Enzyme from Bovine Brain, Generation of Monoclonal Antibodies, and Immunocytochemical Localization of the Enzyme in Glial Cells of Neural Primary Cultures , 1993, Journal of neurochemistry.
[152] Paul S Mischel,et al. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis , 2009, Proceedings of the National Academy of Sciences.
[153] P. Groot. Acyl-CoA synthetases in guinea-pig liver mitochondria. Purification and characterization of a distinct propionyl-CoA synthetase. , 1976, Biochimica et biophysica acta.
[154] J. Phang,et al. A Novel Function for Hydroxyproline Oxidase in Apoptosis through Generation of Reactive Oxygen Species* , 2008, Journal of Biological Chemistry.
[155] J. Brunet,et al. Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals. , 2008, Anticancer research.
[156] N. Bansback,et al. The incidence of comorbidities related to obesity and overweight : A systematic review and meta-analysis , 2009 .
[157] J. Phang,et al. Proline oxidase in cultured mammalian cells , 1977, Journal of cellular physiology.
[158] N. Sonenberg,et al. Akt Activates the Mammalian Target of Rapamycin by Regulating Cellular ATP Level and AMPK Activity* , 2005, Journal of Biological Chemistry.
[159] S. Kridel,et al. Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat , 2007, Nature Structural &Molecular Biology.
[160] S. Linder,et al. Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2‐deoxyglucose and etomoxir , 2008, International journal of cancer.
[161] Labeling of poly(A) associated RNA in synaptosomes and the other subcellular fractions of rat cerebral cortex in basal conditions and during training , 1982, Journal of neuroscience research.
[162] R. Moreno-Sánchez,et al. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells. , 2006, Toxicology and applied pharmacology.
[163] R. Wheeler,et al. Multicenter phase II trial of brequinar sodium in patients with advanced melanoma. , 1992, Annals of Oncology.
[164] C. Lieber. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. , 1988, The New England journal of medicine.
[165] C. Dang. MYC, microRNAs and glutamine addiction in cancers , 2009, Cell cycle.
[166] C. Lieber. Metabolic effects of acetaldehyde. , 1988, Biochemical Society transactions.
[167] C. Wolberger,et al. N-Lysine Propionylation Controls the Activity of Propionyl-CoA Synthetase* , 2007, Journal of Biological Chemistry.
[168] T. Piva,et al. Oxidation of glutamine in HeLa cells: Role and control of truncated TCA cycles in tumour mitochondria , 1998, Journal of cellular biochemistry.
[169] A. Sols,et al. Pyruvate dehydrogenase complex of ascites tumour. Activation by AMP and other properties of potential significance in metabolic regulation. , 1980, The Biochemical journal.
[170] C. Chaumontet,et al. Expression of mitochondrial HMGCoA synthase and glutaminase in the colonic mucosa is modulated by bacterial species. , 2004, European journal of biochemistry.
[171] W. Knecht,et al. Expression, purification, and characterization of histidine-tagged rat and human flavoenzyme dihydroorotate dehydrogenase. , 1998, Protein expression and purification.
[172] A. Rivera,et al. The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway* , 2005, Journal of Biological Chemistry.
[173] J. Albrecht,et al. Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas , 2005, Neuroscience Letters.
[174] J. Smeitink,et al. Methylmalonic Acid, a Biochemical Hallmark of Methylmalonic Acidurias but No Inhibitor of Mitochondrial Respiratory Chain* , 2003, Journal of Biological Chemistry.
[175] P. Iversen,et al. A Bioactively Modified Fatty Acid Improves Survival and Impairs Metastasis in Preclinical Models of Acute Leukemia , 2006, Clinical Cancer Research.
[176] E. Kvamme,et al. Glutamine transport in brain mitochondria , 2000, Neurochemistry International.
[177] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.
[178] P. Bottoni,et al. Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. , 2007, European journal of pharmacology.
[179] M. Tisdale,et al. Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo , 2002, British Journal of Cancer.
[180] C. Sluse-Goffart,et al. Mitochondrial UCPs: new insights into regulation and impact. , 2006, Biochimica et biophysica acta.
[181] K. Autio,et al. Mitochondrial Fatty Acid Synthesis Type II: More than Just Fatty Acids* , 2009, Journal of Biological Chemistry.
[182] F. López‐Soriano,et al. Amino acid metabolism in tumour-bearing mice. , 1988, The Biochemical journal.
[183] J. Menéndez,et al. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.
[184] T. Seyfried,et al. Targeting energy metabolism in brain cancer: review and hypothesis , 2005, Nutrition & metabolism.
[185] E. Gottlieb,et al. Prolyl hydroxylases as regulators of cell metabolism. , 2009, Biochemical Society transactions.
[186] O. Wieland,et al. Kinetic and regulatory properties of pyruvate dehydrogenase from Ehrlich ascites tumor cells. , 1976, Cancer research.
[187] P. J. Brooks,et al. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. , 2005, Alcohol.
[188] L. Madsen,et al. Impact of mitochondrial beta-oxidation in fatty acid-mediated inhibition of glioma cell proliferation. , 2003, Journal of lipid research.
[189] S. Altuwaijri,et al. Inhibition of β‐oxidative respiration is a therapeutic window associated with the cancer chemo‐preventive activity of PPARγ agonists , 2005 .
[190] B. Ardalan,et al. Mechanism of Resistance of a Variant of P388 Leukemia to L-(αS,5S)-α-Amino-3-chloro-4,5-dihydro-5-isoxazoleacetic Acid (Acivicin) , 1985 .
[191] D. Severson,et al. A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels , 2002, The Journal of Biological Chemistry.
[192] Wei Zhang,et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis , 2009, BMC public health.
[193] N. Hay,et al. Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.
[194] R. Capaldi,et al. Heterogeneous distribution of pyruvate dehydrogenase in the matrix of mitochondria. , 2002, Mitochondrion.
[195] M. Pibiri,et al. Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of hepatoma cells , 2006, Apoptosis.
[196] Jie J. Zheng,et al. The structural biology of type II fatty acid biosynthesis. , 2005, Annual review of biochemistry.
[197] Y. Yonekura,et al. Cytosolic acetyl‐CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl‐CoA/acetate metabolism , 2009, Cancer science.
[198] H P Koeffler,et al. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. , 1998, Cancer research.
[199] M. Anver,et al. Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. , 2009, Cancer research.
[200] J. Kelleher,et al. Acetoacetate metabolism in AS-30D hepatoma cells , 1994, Molecular and Cellular Biochemistry.
[201] E. Chevet,et al. Acute L‐glutamine deprivation compromises VEGF‐a upregulation in A549/8 human carcinoma cells , 2007, Journal of cellular physiology.
[202] R. Busche,et al. LACK OF BUTYRATE IS ASSOCIATED WITH INDUCTION OF BAX AND SUBSEQUENT APOPTOSIS IN THE PROXIMAL COLON OF GUINEA PIG , 1996 .
[203] J. Mcgivan,et al. The transport of glutamine into mammalian cells. , 2007, Frontiers in bioscience : a journal and virtual library.
[204] F. Sharp,et al. Methylmalonyl-CoA Mutase Induction by Cerebral Ischemia and Neurotoxicity of the Mitochondrial Toxin Methylmalonic Acid , 1996, The Journal of Neuroscience.
[205] J. Hamilton,et al. Eicosapentaenoic acid, but not oleic acid, stimulates beta-oxidation in adipocytes. , 2005, Lipids.
[206] J. Hamilton,et al. Eicosapentaenoic acid, but not oleic acid, stimulates β-oxidation in adipocytes , 2005, Lipids.
[207] J. Wands,et al. Expression of Uncoupling Protein-2 in Human Colon Cancer , 2004, Clinical Cancer Research.
[208] M. Gomez-Lazaro,et al. Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS‐dependent pathway , 2005, British journal of pharmacology.
[209] L. Baggetto,et al. Role of acetoin on the regulation of intermediate metabolism of Ehrlich ascites tumor mitochondria: its contribution to membrane cholesterol enrichment modifying passive proton permeability. , 1990, Archives of biochemistry and biophysics.
[210] M. Brosnan,et al. Activation of hepatic glutaminase by spermine. , 1995, The Biochemical journal.
[211] Liying Wang,et al. Reactive Oxygen Species Mediate Caspase Activation and Apoptosis Induced by Lipoic Acid in Human Lung Epithelial Cancer Cells through Bcl-2 Down-Regulation , 2006, Journal of Pharmacology and Experimental Therapeutics.
[212] S. Miyamoto,et al. Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue , 2009, Journal of bioenergetics and biomembranes.
[213] O. Boulat,et al. Evidence for catabolic pathway of propionate metabolism in CNS: expression pattern of methylmalonyl-CoA mutase and propionyl-CoA carboxylase alpha-subunit in developing and adult rat brain , 2009, Neuroscience.
[214] J. C. Aledo,et al. Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. , 2000, The Biochemical journal.
[215] Hyun-soo Cho,et al. Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK. , 2010, Biochemical and biophysical research communications.
[216] J. Leahy,et al. Characterization of a novel metabolic strategy used by drug‐resistant tumor cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[217] C. Pecqueur,et al. UCP2, a metabolic sensor coupling glucose oxidation to mitochondrial metabolism? , 2009, IUBMB life.
[218] S. Weinhouse,et al. Metabolism of neoplastic tissue. V. Fatty acid oxidation in slices of transplanted tumors. , 1953, Cancer research.
[219] A. Colquhoun. Gamma-linolenic acid alters the composition of mitochondrial membrane subfractions, decreases outer mitochondrial membrane binding of hexokinase and alters carnitine palmitoyltransferase I properties in the Walker 256 rat tumour. , 2002, Biochimica et biophysica acta.
[220] B. Fuchs,et al. Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[221] D. Finkelstein,et al. Phase II Trial of Acivicin Versus Etoposide‐Cisplatin in Non‐Small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study , 1994, American journal of clinical oncology.
[222] A. J. Lambert,et al. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. , 2004, Free radical biology & medicine.
[223] E. Bolygo,et al. Studies on the formation of acetoin from acetaldehyde by the pyruvate dehydrogenase complex and its regulation. , 1976, European journal of biochemistry.
[224] Jan Albrecht,et al. Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas , 2004, Neuroreport.
[225] J. Halperin,et al. Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation. , 2001, Cancer research.
[226] M. D. Lloyd,et al. α‐Methylacyl‐CoA racemase – an ‘obscure’ metabolic enzyme takes centre stage , 2008, The FEBS journal.
[227] R. Moreno-Sánchez,et al. Substrate oxidation and ATP supply in AS-30D hepatoma cells. , 2000, Archives of biochemistry and biophysics.
[228] L. Novotný,et al. alpha-Lipoic acid: the potential for use in cancer therapy. , 2008, Neoplasma.
[229] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[230] C. Lenzen,et al. Characterisation of glutamine uptake in rat liver mitochondria. , 1991, European journal of biochemistry.
[231] P. Baumann,et al. Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells , 2009, Molecular Cancer Therapeutics.
[232] J. M. Villalba,et al. Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells. , 2007, Biochemical pharmacology.
[233] G. Maira,et al. The PPARγ ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines , 2004 .
[234] W. Knecht,et al. Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives. , 1998, Biochemical pharmacology.
[235] R. Moreno-Sánchez,et al. Toxic effects of copper-based antineoplastic drugs (Casiopeinas) on mitochondrial functions. , 2003, Biochemical pharmacology.
[236] C. Thompson,et al. Uncoupling protein‐2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis‐derived pyruvate utilization , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[237] J. Borowitz,et al. Uncoupling Protein-2 Up-regulation and Enhanced Cyanide Toxicity are Mediated by PPARα Activation and Oxidative Stress , 2007 .
[238] G. Ansari,et al. Immuno- and Hepato-Toxicity of Dichloroacetic Acid in MRL+/+ and B6C3F1 Mice , 2007, Journal of immunotoxicology.
[239] F. Watanabe,et al. Methylmalonic acid inhibits respiration in rat liver mitochondria. , 1995, The Journal of nutrition.
[240] Robin A. J. Smith,et al. Superoxide Activates Mitochondrial Uncoupling Protein 2 from the Matrix Side , 2002, The Journal of Biological Chemistry.
[241] S. Chirala,et al. The subcellular localization of acetyl-CoA carboxylase 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[242] D. Blask,et al. Dietary factors and growth and metabolism in experimental tumors. , 2007, The Journal of nutritional biochemistry.
[243] C. Harding,et al. Intracerebral accumulation of glutaric and 3‐hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl‐CoA dehydrogenase deficiency , 2006, Journal of neurochemistry.
[244] J. Świerczyński,et al. Malic enzyme in human liver. Intracellular distribution, purification and properties of cytosolic isozyme. , 1991, European journal of biochemistry.
[245] Xiu-fang Wang,et al. Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. , 2007, Molecular aspects of medicine.
[246] R. Lill,et al. Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase. , 2000, European journal of biochemistry.
[247] F. Hird,et al. The oxidation of proline by mitochondrial preparations. , 1986, Comparative biochemistry and physiology. B, Comparative biochemistry.
[248] M. Brand,et al. Stimulation of mitochondrial proton conductance by hydroxynonenal requires a high membrane potential , 2008, Bioscience reports.
[249] M. Baumgartner,et al. Causes of and diagnostic approach to methylmalonic acidurias , 2008, Journal of Inherited Metabolic Disease.
[250] Brice A P Wilson,et al. Design, synthesis, and in vitro testing of alpha-methylacyl-CoA racemase inhibitors. , 2007, Journal of medicinal chemistry.
[251] M. Yoshino,et al. Effects of short and medium chain length fatty acids on pyruvate oxidation by cultured human fibroblasts and rat liver mitochondria , 1984, Journal of Inherited Metabolic Disease.
[252] J. Menéndez,et al. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis. , 2005, Medical hypotheses.
[253] S. Kridel,et al. Fatty acid synthase activity in tumor cells. , 2008, Sub-cellular biochemistry.
[254] Andrew C. Li,et al. Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis. , 2006, Annual review of pharmacology and toxicology.
[255] V. Ganapathy,et al. Identity of SMCT1 (SLC5A8) as a neuron‐specific Na+‐coupled transporter for active uptake of l‐lactate and ketone bodies in the brain , 2006, Journal of neurochemistry.
[256] M. Szmitkowski,et al. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[257] I. Edwards,et al. Omega-3 Fatty Acids and PPARγ in Cancer , 2008, PPAR research.
[258] Jeffrey W. Smith,et al. Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity , 2004, Cancer Research.
[259] R. Moreno-Sánchez,et al. Suppression of Tumor Growth In vivo by the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II , 2009, Clinical Cancer Research.
[260] E. Weiderpass,et al. Impact of diet on breast cancer risk , 2009, Current opinion in obstetrics & gynecology.
[261] N. Curthoys,et al. Inhibition by glutamate of phosphate-dependent glutaminase of rat kidney. , 1982, The Biochemical journal.
[262] H. Keun,et al. Citrate transport and metabolism in mammalian cells , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[263] Samuel Singer,et al. Differentiation and reversal of malignant changes in colon cancer through PPARγ , 1998, Nature Medicine.
[264] R. Moreno-Sánchez,et al. The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells? , 2009, BioFactors.
[265] W. Malaisse,et al. Enzyme-to-enzyme channelling of Krebs cycle metabolic intermediates in Caco-2 cells exposed to [2-13c]propionate. , 1996, The Biochemical journal.
[266] T. Itoh,et al. Peroxisome proliferator activated receptor γ and oxidized docosahexaenoic acids as new class of ligand , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.
[267] E. Gabrielson,et al. Selective Inhibition of Fatty Acid Synthase for Lung Cancer Treatment , 2007, Clinical Cancer Research.
[268] R. Brady,et al. The synthesis of radioactive cholesterol and fatty acids in vitro. , 1951, The Journal of biological chemistry.
[269] M. Wajner,et al. Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake , 2008, Journal of Inherited Metabolic Disease.
[270] H. Morris,et al. Kinetic characteristics of citrate influx and efflux with mitochondria from Morris hepatomas 3924A and 16. , 1982, Cancer research.
[271] P. Mcgeer,et al. LOCALIZATION OF GLUTAMINASE IN THE RAT NEOSTRIATUM , 1979, Journal of neurochemistry.
[272] H. Cheon,et al. Apoptotic Action of Peroxisome Proliferator-Activated Receptor-γ Activation in Human Non–Small-Cell Lung Cancer Is Mediated via Proline Oxidase-Induced Reactive Oxygen Species Formation , 2007, Molecular Pharmacology.
[273] Emma Saavedra,et al. Energy metabolism in tumor cells , 2007, The FEBS journal.
[274] J. Tildon,et al. Utilization of ketone bodies and glucose by established neural cell lines , 1982, Journal of neuroscience research.
[275] T. Galeotti,et al. Transport of pyruvate in mitochondria from different tumor cells. , 1983, Cancer research.
[276] V. Ganapathy,et al. Sodium-coupled Monocarboxylate Transporters in Normal Tissues and in Cancer , 2008, The AAPS Journal.
[277] Hiroyuki Yamamoto,et al. Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis , 2006, Experimental biology and medicine.
[278] S. Mazurek,et al. Effect of Extracellular AMP on Cell Proliferation and Metabolism of Breast Cancer Cell Lines with High and Low Glycolytic Rates* , 1997, The Journal of Biological Chemistry.
[279] J. Swinnen,et al. Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. , 2007, Cancer research.
[280] Barbara M. Bakker,et al. Quantitative Analysis of the High Temperature-induced Glycolytic Flux Increase in Saccharomyces cerevisiae Reveals Dominant Metabolic Regulation* , 2008, Journal of Biological Chemistry.
[281] R. Moreno-Sánchez,et al. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. , 2009, Mini reviews in medicinal chemistry.
[282] M. Pibiri,et al. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. , 2007, Apoptosis : an international journal on programmed cell death.